All News

Register for OTC Hearing Aids – Mastering the Market and the Business Model to Maximize Opportunities in Your Practice. This three-part webinar series, featuring Dr. Brent Edwards, Dr. Larry Humes, and Dr. Michael Valente will offer attendees valuable insight into the OTC hearing aid market, including consumer dynamics, and demonstrates how to maximize business opportunities in your practice.

This timely webinar series, underwritten by Phonak, is open to ADA members and audiologists who are interested in a complementary ADA trial membership (trial membership limited to new members only, please). Attendees may register for one, two, or all three sessions.

Register for OTC Hearing Aids – Mastering the Market and the Business Model to Maximize Opportunities in Your Practice. This three-part webinar series, featuring Dr. Brent Edwards, Dr. Larry Humes, and Dr. Michael Valente will offer attendees valuable insight into the OTC hearing aid market, including consumer dynamics, and demonstrates how to maximize business opportunities in your practice.

This timely webinar series, underwritten by Phonak, is open to ADA members and audiologists who are interested in a complementary ADA trial membership (trial membership limited to new members only, please). Attendees may register for one, two, or all three sessions.

The U.S. Consumer Product Safety Commission (CPSC) has announced that it will exercise enforcement discretion under Reese’s Law for zinc-air button and coin cell batteries used in hearing aids until March 8, 2024, citing possible shortages and a low risk of serious injury. ADA and other organizations submitted requests to the agency to delay enforcement of Reese’s Law and we are pleased that the agency has taken this action.

Register for OTC Hearing Aids – Mastering the Market and the Business Model to Maximize Opportunities in Your Practice. This three-part webinar series, featuring Dr. Brent Edwards, Dr. Larry Humes, and Dr. Michael Valente will offer attendees valuable insight into the OTC hearing aid market, including consumer dynamics, and demonstrates how to maximize business opportunities in your practice.

This timely webinar series, underwritten by Phonak, is open to ADA members and audiologists who are interested in a complementary ADA trial membership (trial membership limited to new members only, please). Attendees may register for one, two, or all three sessions.

The Academy of Doctors of Audiology (ADA) has prepared a comprehensive resource for ADA members in response to the Centers for Medicare and Medicaid Services (CMS) CY 2023 Physician Fee Schedule Final Rule.

This members-only resource includes a breakdown of the CMS provisions, requirements, codes, constraints, and timelines specific to the allowance for certain non-acute hearing assessment services to be eligible for Medicare Part B coverage without a physician order and provides general guidance for audiology practices.

FRANKFORT, Ky. — The Academy of Doctors of Audiology (ADA), the leading national audiology association dedicated to autonomous practice, has named David Akbari, Au.D., Senior Medical Science, clinical and Regulatory Affairs Liaison at Intricon Corporation, as the recipient of the prestigious ADA Hearing Industry Leadership Award.

The Academy of Doctors of Audiology (ADA) has prepared a comprehensive resource for ADA members in response to the Centers for Medicare and Medicaid Services (CMS) CY 2023 Physician Fee Schedule Final Rule.

This members-only resource includes a breakdown of the CMS provisions, requirements, codes, constraints, and timelines specific to the allowance for certain non-acute hearing assessment services to be eligible for Medicare Part B coverage without a physician order and provides general guidance for audiology practices.

Yesterday, the Centers for Medicare and Medicaid Services (CMS) released their Calendar Year 2023 Physician Fee Schedule (PFS) Final Rule. You can review the Rule below:

We hope you enjoyed your time at the Gaylord Texan for AuDacity 2022, and will take home actionable insights on improving your business practices and patient services.

Click here to view photos from AuDacity 2022! More photos will be added over the coming weeks.

Today, the U.S. Food and Drug Administration (FDA) distributed a letter to state officials providing important clarifications about the Final Rule on OTC Hearing Aids.

In part, the letter states, “We have received questions about some implications of these actions, including who may prescribe hearing aids and whether medical evaluations are necessary to obtain non-OTC hearing aids, which will be defined as prescription hearing aids under the rule. We clarify below that the final rule: